Abstract:Therapeutic Advances in Drug Safety, Volume 15, Issue , January-December 2024. Background:Cefuroxime has played a crucial role in the prevention and treatment of bacterial infections. However, the differences in adverse events across formulations and routes remain unclear.Objectives:This study aimed to investigate the post-marketing safety of cefuroxime, particularly concerning formulations and routes.Design:A retrospective pharmacovigilance study of cefuroxime was conducted using the data from Food and Drug Administration Adverse Event Reporting System database.Methods:The clinical characteristics and concomitant drugs reported with cefuroxime were investigated. Adverse event signals of cefuroxime were identified based on four disproportionality algorithms. The signal differences of cefuroxime across formulations and routes were further examined.Results:A total of 1810 adverse event reports associated with cefuroxime were identified, and 181 cefuroxime-associated signals were detected. Compared with tablets, injections were more likely to cause preferred terms 'blood pressure decreased' and 'anaphylactic shock'. In addition, system organ class 'eye disorders' significantly increased when cefuroxime was administered intraocularly, underscoring the importance of exercising caution regarding ocular toxicity.Conclusion:The adverse events associated with cefuroxime were significantly different across formulations and routes, which deserve special attention in clinical use.Plain language summaryPost-marketing safety concerns with cefuroximeBackground:Cefuroxime is a commonly used antibiotic. This study investigated the safety of cefuroxime using Food and Drug Administration Adverse Event Reporting System database.Research design and methods:We analyzed the clinical characteristics and concomitant drugs reported with cefuroxime. Then, we detected the signals of cefuroxime. We further examined the signal differences of cefuroxime across formulations and routes.Results:We retrieved 1810 reports and identified 181 signals associated with cefuroxime. In comparison to tablets, injections had a higher likelihood of causing decreased blood pressure and anaphylactic shock. Furthermore, the administration of cefuroxime intraocularly increased the possibility of experiencing eye disorders.Conclusion:The signals associated with cefuroxime were significantly different across formulations and routes, which deserve special attention in clinical use.

A multi-center prospective comparative study on the clinical safety of isepamicin (Exacin)

Adverse Drug Reactions Induced by Gatifloxacin:Analysis of 866 Cases During 2003～2006

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Comparison between mupirocin and other drugs as gentamicin for preventing peritoneal dialysis related infections

Clinical Trial on Augmentin Against Acute Exacerbation of Chronic Bronchitis (AECB) in Adults

Clinical Trial on Gatifloxacin Against Acute Exacerbation of Chronic Bronchitis (AECB) in Adults

Analysis on 522 cases of antibacterial-related adverse drug reaction/event reports

Analysis of adverse reactions/adverse events induced by etimicin in Beijing medical institutions

A Multicenter Clinical Trial on the Efficacy and Safety of Piperacillin/tazobactam for the Treatment of Patients with Hospital Acquired Pneumonia: Treatment of Hospital Acquired Pneumonia Forum in Huadong Area.

Safety Evaluation and Risk Management of Iohexol Injection

Comparision and Analysis on the Safety Issues of Gatifloxacin in Home and Abroad

Analysis on 428 Cases Adverse Drug Reaction/event Reports of Antibacterial Agents

The multi-center clinical study of etimicin injection against acute bacterial infections

A Randomized Controlled Clinical Trial of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Bacterial Infections

A randomized controlled open study of ampicillin/sulbactum in the treatment of 172 cases with bacterial infections

A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime

[Comparison of efficacy and safety between elacycline and polymyxin for complicated intra-abdominal infections caused by multidrug-resistant bacteria]

The clinical safety evaluation on flucloxicillin capsule of 1021 cases

Analysis of Safety Difference of 10 Kinds of Commonly Used Anti-Infective Agents with Same Generic Drugs Name Based on the Adverse Drug Reaction Data

A Multicenter,randomized Controlled Clinical Trial of Imported Amoxicillin-Sulbactam in the Treatment of Community-Acquired Pneumonia

Analysis of the Adverse Drug Reactions Reports of 139 Cases